How to Increase Access to Insomnia Therapies with the AASM’s Jennifer L. Martin
Jennifer L. Martin, PhD, speaks about the challenges faced by people with insomnia disorder in accessing CBT-I and pharmaceuticals, as well as posits solutions.
Category: Cognitive Behavioral Therapy
Cognitive Behavioral Therapy
Latest
Cognitive Behavioral Therapy
Latest
Somryst for Insomnia Gets HCPCS Code
The new HCPCS code for Somryst encompasses "Prescription Digital Behavioral Therapy, FDA Cleared, per Course of Treatment."
Cognitive Behavioral Therapy
LatestSorry, No Posts Found
How to Treat Patients with Chronic Insomnia Disorder
The AASM publishes a guideline that evaluates therapies for patients who experience months-long problems falling or staying asleep.
Read More
More Investment in Pear Therapeutics to Accelerate Reimbursement Coverage for Digital CBT-I
A new strategic investor is investing $20 million in Pear Therapeutics, bringing the total Series D investment to $100 million.
Read More
CBT-I Works When Delivered By Phone to Older Adults
Many people can’t get insomnia treatment because they live in areas with limited access to health care, either in person or over the internet.
Read More
Digital Cognitive Behavioral Therapy for Insomnia Comparison Guide
Compare distribution platforms, data transmittal, available physician reports, payment options, FDA status, internet requirements, and supporting studies for digital CBT-I options.
Read More
Digital CBT Is Most Cost Effective Option for Poor Sleep, Finds New Study
The study examined the cost effectiveness of digital CBT over a six-month period and measured the direct and indirect costs of insomnia.
Read More
New Guideline Supports Behavioral, Psychological Treatments for Insomnia
The American Academy of Sleep Medicine has published a new clinical practice guideline for chronic insomnia disorder in adults.
Read MoreDigital CBT-I Maker Completes Series D Financing & Plans to Use It to Accelerate Reimbursement Coverage
Pear will use the financing to accelerate reimbursement coverage for its products, creating a market access pathway in the prescription digital therapeutics industry.
Read MoreSleepio CBT-I Linked to Alleviation of Depression Symptoms
Analyses revealed a significant proportion of the improvements in depressive symptoms were caused by the improvements in sleep.
Read More
Somryst Prescription Digital CBT-I Now Available to Insomnia Patients
Pear Therapeutics’s Somryst, a prescription digital therapeutic for use in the treatment of patients with chronic insomnia, is now available for patient use.
Read More
Dementia Caregivers’ Stress Leads to Sleep Deprivation
Disrupted sleep is a significant factor in predicting stress on carers and in predicting placing a loved one into long-term care.
Read More
Pear Therapeutics Wins Prix Galien USA Award for Somryst as Best Digital Health Product
The award recognizes the cognitive behavioral therapy for insomnia software for impacting patient care through innovation.
Read More
CBT-I Works in Young Drinkers to Reduce Insomnia Symptoms & May Help Lessen Alcohol Use Too
The potential for insomnia treatment to influence alcohol-related consequences has implications for alcohol use among young adults.
Read More
Nox Health Expands Cognitive Behavioral Therapy Program for Insomnia
SleepCharge by Nox Health launches Restful Mind, a cognitive behavioral therapy for insomnia program that features expert-led videos.
Read More
CBT-I Can Also Help Insomnia Patients Improve Depression, Anxiety, & Stress
Australian researches studied the impact of depression, anxiety, and stress on response to CBT-I, in 455 real-world insomnia patients.
Read More
Now There’s Evidence Digital CBT-I Works in Other Languages Too
A team at the Norwegian University of Science and Technology’s has compared a Norwegian-language version of SHUTi with online patient education about sleep.
Read More